NeonMind Purchases Synthetic Psilocybin from Psygen Labs Feb 24 • 6 min read NeonMind Biosciences Inc. announced that it has purchased an initial order of GMP grade psilocybin from Psygen Labs Inc.
PharmaTher Announces Research Collaboration for Microneedle Delivery of Psychedelic Pharmaceuticals Feb 23 • 4 min read PharmaTher Inc. announced that they have entered into a sponsored research agreement with the Terasaki Institute to develop a novel microneedle patch that aims to deliver psychedelic pharmaceuticals.
Awakn Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Trial Feb 22 • 3 min read Awakn Life Sciences Inc. announced the publication of results from its CMO Dr. Ben Sessa’s Bristol Imperial MDMA in Alcoholism (BIMA) trial.
Mindset Pharma Added to North American Psychedelics Index Feb 19 • 3 min read Mindset Pharma Inc. announced that it has been added to the North American Psychedelics Index.
Revive Therapeutics Acquires Unique Psilocybin Assets Feb 18 • 5 min read Revive Therapeutics Ltd. announced that it has entered into an asset purchase agreement with Newscope Capital Corporation to acquire the full rights to PharmaTher Inc.’s intellectual property pertaining to psilocybin.